Composition:

Each 1 ml contains 5mg Metronidazole.

Pharmaceutical Dosage Form:

Solution for I.V infusion

Indications:

Treatment of Anaerobic Infections

• Metroflag is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.
• Aerobic and anaerobic infection, antibiotics appropriate for the treatment of the aerobic infection should be used in addition to Metroflag.
• Metroflag is effective in Bacteroides fragilis infections resistant to clindamycin, chloramphenicol and penicillin.
• Intra-Abdominal Infections including peritonitis, intra-abdominal abscess and liver abscess, caused by Bacteroides species including the B. fragilis group (B. fragilis, B. distasonis, B. ovatus, B. thetaiotaomicron, B. vulgatus), Clostridium species, Eubacterium species, Peptococcus species and Peptostreptococcus species.
• Skin and Skin Structure Infections caused by Bacteroides species including the B. fragilis group, Clostridium species, Peptococcus species, Peptostreptococcus species and Fusobacterium species.
• Gynecologic Infections including endometritis, endomyometritis, tubo-ovarian abscess and postsurgical vaginal cuff infection caused by Bacteroides species including the B. fragilis group, Clostridium species, Peptostreptococcus species and Fusobacterium species.
• Bacterial Septicemia caused by Bacteroides species including the B. fragilis group and Clostridium species.
• Bone and Joint Infections as adjunctive therapy, caused by Bacteroides species including the B. fragilis group.
• Central Nervous System (CNS) Infections, including meningitis and brain abscess, caused by Bacteroides species including the B. fragilis group.
• Lower Respiratory Tract Infections, including pneumonia, empyema and lung abscess, caused by Bacteroides species including the B. fragilis group.
• Endocarditis caused by Bacteroides species including the B. fragilis group.

Prophylaxis

• The prophylactic administration of Metronidazole preoperatively, intraoperatively and postoperatively may reduce the incidence of postoperative infection in patients undergoing elective colorectal surgery which is classified as contaminated or potentially contaminated.
• Prophylactic use of Metronidazole should be discontinued within 12 hours after surgery.

Dosage &Administration:

For dosage details leaflet available upon request.

Package and Storage:

Carton box containing 100ml solution in a transparent glass vials + insert leaflet
Store at temperature not exceeding 30°C and used directly after opening.